CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 50 of 98 entries

View as:

Implementation of Early Detection and Early Intervention Service Delivery in Infants at Risk for Cerebral Palsy to Promote Infants' Psychomotor Development and Maternal Health

Phase: N/A Priority: Normal

NCT ID: NCT04622787 Org: User:

Start: 06/01/21 End: 12/31/23 Due: 12/31/24

Treatment Outcomes in Patients With Muscular Temporo-mandibular Joint Disorders

Phase: N/A Priority: Normal

NCT ID: NCT06339736 Org: User:

Start: 01/10/22 End: 03/28/25 Due: 03/28/26

A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study

Phase: N/A Priority: Normal

NCT ID: NCT05049603 Org: User:

Start: 01/01/24 End: 12/31/26 Due: 12/31/27

Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy

Phase: N/A Priority: Normal

NCT ID: NCT03498417 Org: User:

Start: 06/20/18 End: 07/20/18 Due: 07/20/19

Arterial Waveform Analysis Applying Different Positive End-Expiratory Pressure (PEEP) Levels in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT03294928 Org: User:

Start: 09/28/17 End: 10/15/17 Due: 10/15/18

"Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON)

Phase: N/A Priority: Normal

NCT ID: NCT06336941 Org: User:

Start: 06/07/18 End: 12/31/30 Due: 12/31/31

Association Between Phthalates Exposure and Renal Function Impairment in TYpe 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT03622957 Org: User:

Start: 08/10/18 End: 09/03/18 Due: 09/03/19

Risk Factors and Measures to Prevent Liver and Pancreas Complications in Pediatric Patients After HSCT

Phase: N/A Priority: Normal

NCT ID: NCT04423237 Org: User:

Start: 09/30/20 End: 12/31/24 Due: 12/31/25

ERN ReCONNET Study on COVID-19 Vaccination in Rare and Complex Connective Tissue Disease (VACCINATE)

Phase: N/A Priority: Normal

NCT ID: NCT04702295 Org: User:

Start: 02/28/21 End: 08/31/23 Due: 08/31/24

Effects of Empagliflozin on Endogenous Glucose Production in End Stage Renal Disease(ESRD).

Phase: N/A Priority: Normal

NCT ID: NCT03713190 Org: User:

Start: 09/10/18 End: 03/15/20 Due: 03/15/21

ReModeling in ST-elevation myocARrdial Infarction: a Comparison of Left VEntricuLar Functions in Long-term Follow-up Among STEMI Patients

Phase: N/A Priority: Normal

NCT ID: NCT07041840 Org: User:

Start: 01/01/24 End: 01/01/27 Due: 01/01/28

24-h Energy Expenditure and Anti-obesity Medication

Phase: N/A Priority: Normal

NCT ID: NCT07041983 Org: User:

Start: 07/01/25 End: 12/01/26 Due: 12/01/27

Amelogenins and Systemic Inflammation After Periodontal Surgical Therapy

Phase: N/A Priority: Normal

NCT ID: NCT03590093 Org: User:

Start: 11/01/13 End: 06/01/18 Due: 06/01/19

Phenotyping Individuals With Neo-diagnosed Type 2 Diabetes at Risk for All-cause Mortality

Phase: N/A Priority: Normal

NCT ID: NCT04453605 Org: User:

Start: 01/01/08 End: 12/31/18 Due: 12/31/19

Direct Oral Anticoagulants and Management of Blleding Following Dental Extractions. A Prospective Cohort Study.

Phase: N/A Priority: Normal

NCT ID: NCT06365242 Org: User:

Start: 07/23/20 End: 12/23/22 Due: 12/23/23

Evaluation of Difficulty Score for Robotic Pancreatoduodenectomy

Phase: N/A Priority: Normal

NCT ID: NCT04662346 Org: User:

Start: 12/01/20 End: 02/28/21 Due: 02/28/22

Effects of a Mindfulness Intervention on Temperament, Anxiety and Depression: the Mind the Child Study

Phase: N/A Priority: Normal

NCT ID: NCT05179096 Org: User:

Start: 08/20/21 End: 11/30/21 Due: 11/30/22

Fetal Autonomic Nervous sysTem Evaluation

Phase: N/A Priority: Normal

NCT ID: NCT06330987 Org: User:

Start: 08/13/19 End: 12/28/25 Due: 12/28/26

Prostate Impendance Test Project

Phase: N/A Priority: Normal

NCT ID: NCT03428087 Org: User:

Start: 07/01/17 End: 06/30/18 Due: 06/30/19

Acute-phase Response & Periodontal Treatment in Diabetes Affected Patients

Phase: N/A Priority: Normal

NCT ID: NCT03087266 Org: User:

Start: 06/01/16 End: 11/30/20 Due: 11/30/21

Acute Inflammation After Wisdom Tooth Removal

Phase: N/A Priority: Normal

NCT ID: NCT03048175 Org: User:

Start: 04/19/07 End: 06/30/16 Due: 06/30/17

SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of the Genito-urinary Tract and Risk of Infections.

Phase: N/A Priority: Normal

NCT ID: NCT04735042 Org: User:

Start: 10/07/20 End: 04/07/22 Due: 04/07/23

Genetics and Epigenetics of Graves' Orbitopathy

Phase: N/A Priority: Normal

NCT ID: NCT04488406 Org: User:

Start: 01/01/20 End: 03/31/20 Due: 03/31/21

Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT04501991 Org: User:

Start: 03/11/20 End: 06/30/20 Due: 06/30/21

Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus

Phase: N/A Priority: Normal

NCT ID: NCT03804723 Org: User:

Start: 06/30/19 End: 09/30/23 Due: 09/30/24

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Implementation of Early Detection and Early Intervention Service Delivery in Infants at Risk for Cerebral Palsy to Promote Infants' Psychomotor Development and Maternal Health	NCT04622787	University of Pisa	user2@example.com	None	2021-06-01	2023-12-31	2024-12-31	-	-	2025-07-14
Treatment Outcomes in Patients With Muscular Temporo-mandibular Joint Disorders	NCT06339736	University of Pisa	user2@example.com	None	2022-01-10	2025-03-28	2026-03-28	-	-	2025-07-14
A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study	NCT05049603	University of Pisa	user2@example.com	None	2024-01-01	2026-12-31	2027-12-31	-	-	2025-07-14
Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy	NCT03498417	University of Pisa	user2@example.com	None	2018-06-20	2018-07-20	2019-07-20	-	-	2025-07-14
Arterial Waveform Analysis Applying Different Positive End-Expiratory Pressure (PEEP) Levels in Healthy Volunteers	NCT03294928	University of Pisa	user2@example.com	None	2017-09-28	2017-10-15	2018-10-15	-	-	2025-07-14
"Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON)	NCT06336941	University of Pisa	user2@example.com	None	2018-06-07	2030-12-31	2031-12-31	-	-	2025-07-14
Association Between Phthalates Exposure and Renal Function Impairment in TYpe 2 Diabetes	NCT03622957	University of Pisa	user2@example.com	None	2018-08-10	2018-09-03	2019-09-03	-	-	2025-07-14
Risk Factors and Measures to Prevent Liver and Pancreas Complications in Pediatric Patients After HSCT	NCT04423237	University of Pisa	user2@example.com	None	2020-09-30	2024-12-31	2025-12-31	-	-	2025-07-14
ERN ReCONNET Study on COVID-19 Vaccination in Rare and Complex Connective Tissue Disease (VACCINATE)	NCT04702295	University of Pisa	user2@example.com	None	2021-02-28	2023-08-31	2024-08-31	-	-	2025-07-14
Effects of Empagliflozin on Endogenous Glucose Production in End Stage Renal Disease(ESRD).	NCT03713190	University of Pisa	user2@example.com	None	2018-09-10	2020-03-15	2021-03-15	-	-	2025-07-14
ReModeling in ST-elevation myocARrdial Infarction: a Comparison of Left VEntricuLar Functions in Long-term Follow-up Among STEMI Patients	NCT07041840	University of Pisa	user2@example.com	None	2024-01-01	2027-01-01	2028-01-01	-	-	2025-07-14
24-h Energy Expenditure and Anti-obesity Medication	NCT07041983	University of Pisa	user2@example.com	None	2025-07-01	2026-12-01	2027-12-01	-	-	2025-07-14
Amelogenins and Systemic Inflammation After Periodontal Surgical Therapy	NCT03590093	University of Pisa	user2@example.com	None	2013-11-01	2018-06-01	2019-06-01	-	-	2025-07-14
Phenotyping Individuals With Neo-diagnosed Type 2 Diabetes at Risk for All-cause Mortality	NCT04453605	University of Pisa	user2@example.com	None	2008-01-01	2018-12-31	2019-12-31	-	-	2025-07-14
Direct Oral Anticoagulants and Management of Blleding Following Dental Extractions. A Prospective Cohort Study.	NCT06365242	University of Pisa	user2@example.com	None	2020-07-23	2022-12-23	2023-12-23	-	-	2025-07-14
Evaluation of Difficulty Score for Robotic Pancreatoduodenectomy	NCT04662346	University of Pisa	user2@example.com	None	2020-12-01	2021-02-28	2022-02-28	-	-	2025-07-14
Effects of a Mindfulness Intervention on Temperament, Anxiety and Depression: the Mind the Child Study	NCT05179096	University of Pisa	user2@example.com	None	2021-08-20	2021-11-30	2022-11-30	-	-	2025-07-14
Fetal Autonomic Nervous sysTem Evaluation	NCT06330987	University of Pisa	user2@example.com	None	2019-08-13	2025-12-28	2026-12-28	-	-	2025-07-14
Prostate Impendance Test Project	NCT03428087	University of Pisa	user2@example.com	None	2017-07-01	2018-06-30	2019-06-30	-	-	2025-07-14
Acute-phase Response & Periodontal Treatment in Diabetes Affected Patients	NCT03087266	University of Pisa	user2@example.com	None	2016-06-01	2020-11-30	2021-11-30	-	-	2025-07-14
Acute Inflammation After Wisdom Tooth Removal	NCT03048175	University of Pisa	user2@example.com	None	2007-04-19	2016-06-30	2017-06-30	-	-	2025-07-14
SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of the Genito-urinary Tract and Risk of Infections.	NCT04735042	University of Pisa	user2@example.com	None	2020-10-07	2022-04-07	2023-04-07	-	-	2025-07-14
Genetics and Epigenetics of Graves' Orbitopathy	NCT04488406	University of Pisa	user2@example.com	None	2020-01-01	2020-03-31	2021-03-31	-	-	2025-07-14
Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes	NCT04501991	University of Pisa	user2@example.com	None	2020-03-11	2020-06-30	2021-06-30	-	-	2025-07-14
Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus	NCT03804723	University of Pisa	user2@example.com	None	2019-06-30	2023-09-30	2024-09-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance